News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
FDA Oncology – ASCO is accepting applications for the October 2024 Hybrid FDA- ASCO Fellows’ Day
Aug 2, 2024, 01:49

FDA Oncology – ASCO is accepting applications for the October 2024 Hybrid FDA- ASCO Fellows’ Day

FDA Oncology shared on X:

“ASCO is now accepting applications for the October 2024 Hybrid FDA- ASCO Fellows’ Day Workshop through August 5.

Photo: Spring 2024 FDA-ASCO Fellows Day.”

Source: FDA Oncology/X

ASCO cancer FDA Oncology FDA-ASCO Fellows Day OncoDaily Oncology
Special Coverage
Blog
Dec 21, 2024, 13:43
National University Cancer Institute, Singapore clinicians had the exciting opportunity to present their work at the ESMO Asia 2024
Blog
Dec 21, 2024, 13:40
UICC - Welcoming the newest member, The World Hepatitis Alliance
Blog
Dec 21, 2024, 13:35
Pediatric Cancer and Blood Disorders Center of Armenia - Prioritizing the continuous education and knowledge exchange of the medical staff
Blog
Dec 21, 2024, 13:33
SIOP Europe - International Childhood Cancer Day 2025
Blog
Dec 21, 2024, 13:29
Canadian Cancer Society - How 5 organizations are working to take on cancer’s biggest issues
Radiotherapy
Dec 21, 2024, 13:20
What Is Flash Radiotherapy and How It Works? Pros and Cons
Science
Dec 21, 2024, 13:18
Ruzanna Papyan: The Impact of Telemedicine on Improving Soft Tissue and Bone Tumor Management in Armenia
Science
Dec 21, 2024, 13:12
Myeloma Paper of the Day, December 21st, suggested by Robert Orlowski
Blog
Dec 21, 2024, 13:06
Varsha Gupta: Fertility preservation causes no significant delay in cancer treatment initiation and outcomes
Cancer Types
Dec 21, 2024, 13:05
Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment
Insight
Dec 21, 2024, 12:45
Practical treatment strategies and novel therapies for HR positive/HER2 negative advanced breast cancer
Insight
Dec 21, 2024, 12:39
Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer